Method provides improved assay performance for HDL cholesterol testing with low interference from endogenous triglyceride and reduced reactivity to LDL
Bayer Diagnostics has launched a new Direct HDL cholesterol method and a new liquid stable CO2 for use on the high throughput Advia 1650 and Advia 2400 clinical chemistry systems.
The Advia Direct HDL method provides laboratories with improved assay performance for HDL cholesterol testing with low interference from endogenous triglyceride and reduced reactivity to LDL.
While benefiting from calibration stability of 30 days, the new chemistry method also demonstrates a linear range of 5-115mg/dL. The Advia liquid stable CO2 method offers on-board stability of up to 30 days for each reagent wedge.
This in combination with the ready-to use liquid format makes a significant practical difference as well as minimising reagent wastage, says Bayer.
The company says the introduction of these new assays reflects its continued commitment to the development Advia family of clinical chemistry assays.
